Antibiotics and upper respiratory infection: Do some folks think there is a cure for the common cold?

Journal of Family Practice

Volumn 42, Issue 4, 1996, Pages 357-361

  Mainous III, Arch G ^a,d   Hueston, William J ^b,c   Clark, Jonathan R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Eau Claire Family Practice Residency   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

antibiotics; Common cold; drug resistance; health care services; physicians' practice patterns; prescriptions, drug

Indexed keywords

AMOXICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CEPHALOSPORIN DERIVATIVE; DIPHENHYDRAMINE; ERYTHROMYCIN; PROMETHAZINE;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; COMMON COLD; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAID; OTITIS MEDIA; PRESCRIPTION; RHINOPHARYNGITIS; SINUSITIS; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; COMMON COLD; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 0029971522     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. de Melker RA, Kuyvenhoven MM. Management of upper respiratory tract infection in Dutch general practice. Br J Gen Pract 1991; 41:504-7.
2. Burns JL. Mechanisms of bacterial resistance. Pediatr Clin North Am 1995; 42:497-507.
3. Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis 1992;15 (suppl 2):37S-42S.
4. Conus P, Francioli P. Relationship between ceftriaxone use and resistance of Enterobacter species. J Clin Pharm Ther 1992;17:303-5.
5. North D. Controlling the costs of antibiotic resistance. Clin Ther 1993; 15(suppl A):3-11.
6. Bartlett JG, Froggatt JW III. Antibiotic resistance. Arch Otolaryngol Head Neck Surg 1995; 121:392-6.
7. Molstad S, Arvidsson E, Eliasson I, et al. Production of beta-lactamase in respiratory tract bacteria in children: relationship to antibiotic use. Scand J Prim Health Care 1992; 10:16-20.
8. Benson V, Marano MA. Current estimates from the National Health Interview Survey. Vital Health Statistics series 10, No. 189. Hyattsville, Md: National Center for Health Statistics, 1994.
9. Gwaltney J. The common cold. In: Mandell G, Douglas R, Bennett I, eds. Principles and practice of infectious disease. New York, NY: Churchill Livingstone, 1990:489-93.
10. Hilding DA. Literature review: the common cold. Ear Nose Throat J 1994; 73:639-43, 646-7.
11. Sperber SJ, Hunger SB, Schwartz B, Pestka S. Anti-rhinoviral activity of recombinant and hybrid species of interferon alpha. Antiviral Res 1993; 22:121-9.
12. Gwaltney JM Jr. Combined antiviral and antimediator treatment of rhinovirus colds. J Infect Dis 1992; 166:776-82.
13. Smith MBH, Feldman W. Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991. JAMA 1993; 269:2258-63.
14. Neill RA. Upper respiratory infection. In: Rakel RE, ed. Saunders' manual of medical practice. Philadelphia, Pa: WB Saunders Co, 1996:105-7.
15. McGuffey EC. Treatment of the common cold in children. Am Pharm 1994; NS34:19-20.
16. Lowenstein SR, Parrino TA. Management of the common cold. Adv Intern Med 1987; 32:207-34.
17. Mayefsky JF, El-Shinaway Y, Kelleher P. Families who seek care for the common cold in a pediatric emergency department. I Pediatr 1991; 119:933-4.
18. Cowan PF. Patient satisfaction with an office visit for the common cold. J Fam Pract 1987; 24:412-3.
19. Vinson DC, Lutz LJ. The effect of parental expectations on the treatment of children with a cough: a report from ASPN. J Fam Pract 1993; 37:23-7.
20. St Anthony's color-coded ICD-9-CM book for physician payment. Vols 1 and 2, 1994. Alexandria, Va: St Anthony Publishing, 1993.
21. Halfon N, Newacheck PW. Childhood asthma and poverty: differential impacts and utilization of health services. Pediatrics. 1993; 91:56-61.
22. Williams JW Jr, Holleman DR Jr, Samsa GP, Simel DL. Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis. JAMA 1995; 273:1015-21.
23. de Melker RA, Kuyvenhoven MM. Management of upper respiratory tract infections in Dutch family practice. J Fam Pract 1994; 38:353-7.
24. 1994 Red book: pharmacy's fundamental reference. Montvale, NJ: Medical Economics Data Production Company, 1994:100.
25. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16:10513.
26. Bamberger DM, Dahl SL. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital. Arch Intern Med 1992; 152:554-7.
27. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342:1317-22.